Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Sept 3 (Reuters) - Calliditas Therapeutics AB
CALTX.ST :
* TAKES CERTAIN CORPORATE ACTIONS FOLLOWING ANNOUNCEMENT BY
ASAHI
KASEI
* HAS RESOLVED TO APPLY FOR DELISTING OF COMPANY'S COMMON
SHARES
FROM NASDAQ STOCKHOLM, FROM NASDAQ STOCKHOLM
* INTENDS TO FILE A FORM 25 WITH U.S. SECURITIES AND
EXCHANGE
COMMISSION ("SEC") ON OR ABOUT SEPTEMBER 13, 2024
* DELISTING OF ADSS IS EXPECTED TO BECOME EFFECTIVE ON OR
ABOUT
SEPTEMBER 23, 2024
Source text for Eikon: ID:nWkr5Dg68G
Further company coverage: CALTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations